Infectious Disease Diagnostics Market worth $25.43 billion by 2027

The report "Infectious Disease Diagnostics Market by Product & Service(Assay, Kit & Reagent, Instruments), Disease Type(Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology(Immunodiagnostics, PCR, NGS), End User(Hospital, Research Institute) - Global Forecast to 2027", The global infectious disease diagnostics market is expected to reach USD 25.43 billion by 2027 from USD 15.57 billion in 2018, at a CAGR of 5.6%. The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics are some the factors driving the growth of this market.

Browse 85 market data Tables and 35 Figures spread through 170 Pages and in-depth TOC on "Infectious Disease Diagnostics Market by Product & Service(Assay, Kit & Reagent, Instruments), Disease Type(Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology(Immunodiagnostics, PCR, NGS), End User(Hospital, Research Institute) - Global Forecast to 2027"https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html

North America dominated the market in 2018

In 2018, North America accounted for the largest share of the global infectious disease diagnostics market. This largest share is attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.

The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMérieux (France), Bio-Rad (US), and Roche (Switzerland).

Don’t miss out on business opportunities in Infectious Disease Diagnostics Market . Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.